Exact Mass: 491.2635

Exact Mass Matches: 491.2635

Found 45 metabolites which its exact mass value is equals to given mass value 491.2635, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DB-065692

Desoxyepothilone b

C27H41NO5S (491.2705)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents

   

Epothilone D

4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C27H41NO5S (491.2705)


   
   
   
   

Leu Ala Ser Ser Thr

Leu Ala Ser Ser Thr

C20H37N5O9 (491.2591)


   

Gly Thr Ile Thr Thr

Gly Thr Ile Thr Thr

C20H37N5O9 (491.2591)


   

Ala His His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C21H33N9O5 (491.2605)


   

Ala His Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H33N9O5 (491.2605)


   

Ala Lys His His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H33N9O5 (491.2605)


   

His Ala His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C21H33N9O5 (491.2605)


   

His Ala Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H33N9O5 (491.2605)


   

His His Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]hexanoic acid

C21H33N9O5 (491.2605)


   

His His Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]propanoic acid

C21H33N9O5 (491.2605)


   

His Lys Ala His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H33N9O5 (491.2605)


   

His Lys His Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C21H33N9O5 (491.2605)


   

Lys Ala His His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H33N9O5 (491.2605)


   

Lys His Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H33N9O5 (491.2605)


   

Lys His His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C21H33N9O5 (491.2605)


   

GTITT

Gly-Thr-Ile-Thr-Thr

C20H37N5O9 (491.2591)


   

VSSSL

Val-Ser-Ser-Ser-Leu

C20H37N5O9 (491.2591)


   
   

(1R,2S,4R,5R,8R,9S,11S)-2-[[(2R,3S,4S,5S,6R)-3,4-dihydroxy-5-methoxy-6-methyloxan-2-yl]oxymethyl]-9-formyl-5-methyl-13-propan-2-yltetracyclo[7.4.0.02,11.04,8]tridec-12-ene-1-carboxylate

(1R,2S,4R,5R,8R,9S,11S)-2-[[(2R,3S,4S,5S,6R)-3,4-dihydroxy-5-methoxy-6-methyloxan-2-yl]oxymethyl]-9-formyl-5-methyl-13-propan-2-yltetracyclo[7.4.0.02,11.04,8]tridec-12-ene-1-carboxylate

C27H39O8- (491.2645)


   

(13E)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

(13E)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C27H41NO5S (491.2705)


   

cyclopropyl-[(1R)-1-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone

cyclopropyl-[(1R)-1-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone

C29H34FN3O3 (491.2584)


   

[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-fluorophenyl)methanone

[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-fluorophenyl)methanone

C29H34FN3O3 (491.2584)


   

[(1S)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-fluorophenyl)methanone

[(1S)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-fluorophenyl)methanone

C29H34FN3O3 (491.2584)


   

cyclopropyl-[(1S)-1-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone

cyclopropyl-[(1S)-1-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone

C29H34FN3O3 (491.2584)


   

18-Deoxycytochalasin Q

18-Deoxycytochalasin Q

C30H37NO5 (491.2672)


   

Lnape 2:0/N-16:2

Lnape 2:0/N-16:2

C23H42NO8P (491.2648)


   

Lnape 16:2/N-2:0

Lnape 16:2/N-2:0

C23H42NO8P (491.2648)


   

[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C23H42NO8P (491.2648)


   

2-[2,3-Di(trimethylsilyloxy)butoxy]-N-[2-(dimethylamino)ethyl]-4-quinolinecarboxamide

2-[2,3-Di(trimethylsilyloxy)butoxy]-N-[2-(dimethylamino)ethyl]-4-quinolinecarboxamide

C24H41N3O4Si2 (491.2635)


   

Epothilone D

Desoxyepothilone b

C27H41NO5S (491.2705)


An epithilone that is epithilone C in which the hydrogen at position 13 of the oxacyclohexadec-13-ene-2,6-dione macrocycle has been replaced by a methyl group. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents

   

phosphatidylethanolamine 18:2 zwitterion

phosphatidylethanolamine 18:2 zwitterion

C23H42NO8P (491.2648)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the two acyl groups contain a total of 18 carbons and 2 double bonds.

   

PE(18:2)

PE(4:0_14:2)

C23H42NO8P (491.2648)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PC(15:2)

PC(4:0_11:2)

C23H42NO8P (491.2648)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   

(2s,5s,10r,13r,14r,17s,18s)-4-ethyl-13,14-dihydroxy-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosan-18-yl (2z)-3-phenylprop-2-enoate

(2s,5s,10r,13r,14r,17s,18s)-4-ethyl-13,14-dihydroxy-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosan-18-yl (2z)-3-phenylprop-2-enoate

C30H37NO5 (491.2672)


   

17-benzyl-19-hydroxy-5,7,14,15-tetramethyl-6-oxo-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-3,9,18-trien-2-yl acetate

17-benzyl-19-hydroxy-5,7,14,15-tetramethyl-6-oxo-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-3,9,18-trien-2-yl acetate

C30H37NO5 (491.2672)


   

(1r,2r,3z,5s,7s,9z,11r,12s,14r,15s,16r,17s)-17-benzyl-19-hydroxy-5,7,14,15-tetramethyl-6-oxo-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-3,9,18-trien-2-yl acetate

(1r,2r,3z,5s,7s,9z,11r,12s,14r,15s,16r,17s)-17-benzyl-19-hydroxy-5,7,14,15-tetramethyl-6-oxo-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-3,9,18-trien-2-yl acetate

C30H37NO5 (491.2672)